Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Rituximab and lung disease.

O'Connor MB, Phelan MJ.

Ir Med J. 2012 Oct;105(9):314. No abstract available.

PMID:
23240291
2.

Rituximab-induced interstitial lung disease: case report and literature review.

Zayen A, Rais H, Rifi H, Ouarda M, Afrit M, Cherif A, Mezline A.

Pharmacology. 2011;87(5-6):318-20. doi: 10.1159/000327681. Epub 2011 May 26.

PMID:
21613805
3.

[Rituximab-induced interstitial lung disease].

Fernández Casares M, Espósito G, González A, Segovia J, Galperín Mde L, Del Valle E.

Medicina (B Aires). 2013;73(4):343-5. Spanish.

4.

Rituximab-induced subacute interstitial pneumonitis: a case report and review of literature.

Subramanian M, Manjunath R, Kilara N, Mohan Rao KN.

J Cancer Res Ther. 2010 Jul-Sep;6(3):344-6. doi: 10.4103/0973-1482.73356. Review.

5.

Risk factors for rituximab-induced interstitial lung diseases in patients with malignant lymphoma.

Cha SI, Choi KJ, Shin KM, Lim J, Yoo SS, Lee J, Lee SY, Kim CH, Park JY.

Respiration. 2013;85(2):175. doi: 10.1159/000345211. Epub 2012 Dec 7. No abstract available.

PMID:
23234874
6.

[Interstitial pneumonitis related to rituximab therapy in primary macroglobulinemia: a case report and literatures review].

Bai X, Yang R, Sun X, Qian J, Zhu H, Cui Q, Wang C, Liu Y.

Zhonghua Xue Ye Xue Za Zhi. 2014 Nov;35(11):1022-3. doi: 10.3760/cma.j.issn.0253-2727.2014.11.017. Review. Chinese. No abstract available.

PMID:
25417884
7.

Rituximab-induced pulmonary disease.

O'Connor MB, Abdullah MF, O'Donovan N, Phelan MJ.

Rheumatol Int. 2012 Sep;32(9):2955-6. doi: 10.1007/s00296-011-2110-9. Epub 2011 Sep 3. No abstract available.

PMID:
21892654
8.

Rituximab-induced lung disease: A systematic literature review.

Lioté H, Lioté F, Séroussi B, Mayaud C, Cadranel J.

Eur Respir J. 2010 Mar;35(3):681-7. doi: 10.1183/09031936.00080209. Epub 2009 Jul 16. Review.

9.

Rituximab-induced pneumonitis mimicking miliary tuberculosis.

Yao CW, Liao WC, Tu CY, Chen HJ, Teseng GC, Yeh SP.

Eur Respir Rev. 2013 Dec;22(130):587-8. doi: 10.1183/09059180.00003813. No abstract available.

10.

Fatal interstitial lung disease induced by rituximab-containing chemotherapy, treatment with TNF-α antagonist and cytokine profiling: a case-report and review of the literature.

Wu Y, Jia Y, Xu J, Shuai X, Wu Y.

J Clin Pharm Ther. 2013 Jun;38(3):249-53. doi: 10.1111/jcpt.12052. Epub 2013 Mar 18.

PMID:
23506410
11.

Rituximab-induced interstitial lung disease in a patient with immune thrombocytopenia purpura.

Child N, O'Carroll M, Berkahn L.

Intern Med J. 2012 Mar;42(3):e12-4. doi: 10.1111/j.1445-5994.2011.02701.x.

PMID:
22432995
12.

Comment on: non-infectious pulmonary toxicity of rituximab: a systematic review.

Patel V, Patel P, Dawson J.

Rheumatology (Oxford). 2012 Nov;51(11):2111-2; author reply 2112-3. doi: 10.1093/rheumatology/kes221. Epub 2012 Sep 4. No abstract available.

13.

Low absolute lymphocyte count and addition of rituximab confer high risk for interstitial pneumonia in patients with diffuse large B-cell lymphoma.

Huang YC, Liu CJ, Liu CY, Pai JT, Hong YC, Teng HW, Hsiao LT, Chao TC, Gau JP, Liu JH, Hsu HC, Chiou TJ, Chen PM, Yu YB, Tzeng CH.

Ann Hematol. 2011 Oct;90(10):1145-51. doi: 10.1007/s00277-011-1268-2. Epub 2011 Jun 7.

PMID:
21647583
14.

Refractory anti-synthetase syndrome treated with rituximab.

Ball EM, Savage EM, Pendleton A.

Rheumatology (Oxford). 2010 May;49(5):1013. doi: 10.1093/rheumatology/kep438. Epub 2009 Dec 23. No abstract available.

15.

Rituximab-induced interstitial pneumonia due to CD8-positive T cell infiltration.

Sato K, Nagai T, Izumi T, Ohmine K, Ozaki K, Muroi K, Ozawa K.

Acta Haematol. 2012;128(2):107-9. doi: 10.1159/000338259. Epub 2012 Jun 29. No abstract available.

PMID:
22760000
16.

Rituximab induced myocardial infarction: A fatal drug reaction.

Arunprasath P, Gobu P, Dubashi B, Satheesh S, Balachander J.

J Cancer Res Ther. 2011 Jul-Sep;7(3):346-8. doi: 10.4103/0973-1482.87003. No abstract available.

17.

Rapid-onset, prolonged bone marrow failure following rituximab therapy of follicular lymphoma.

Debatin L, Schmitt-Graeff A, Veelken H.

Onkologie. 2011;34(6):322-4. doi: 10.1159/000328783. Epub 2011 May 17. No abstract available.

PMID:
21625186
18.

Worsening of psoriasis with rituximab therapy.

Olivieri I, D'Angelo S, Leccese P, Vertone D, Olivieri A.

Clin Exp Rheumatol. 2010 Nov-Dec;28(6):926. Epub 2011 Jan 4. No abstract available.

PMID:
21205468
19.

Incidence of infusion-related reaction to monoclonal antibody rituximab: a national kidney and transplant institute experience.

Montoya JE, Luna HG, Vergara NG, Amparo JR, Cristal-Luna GR.

Ann Acad Med Singapore. 2012 Mar;41(3):125-6. No abstract available.

20.

Rituximab therapy for refractory interstitial lung disease related to antisynthetase syndrome.

Marie I, Dominique S, Janvresse A, Levesque H, Menard JF.

Respir Med. 2012 Apr;106(4):581-7. doi: 10.1016/j.rmed.2012.01.001. Epub 2012 Jan 24.

Items per page

Supplemental Content

Write to the Help Desk